FDA Approved: BLISOVI FE 1/20 — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin's supplemental application for BLISOVI FE 1/20, a generic oral contraceptive containing norethindrone acetate and ethinyl estradiol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• BLISOVI FE 1/20 (Norethindrone acetate and ethinyl estradiol)

Snippet

SUPPL AP for BLISOVI FE 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)